Share Price and Basic Stock Data
Last Updated: December 6, 2025, 10:26 pm
| PEG Ratio | 7.23 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vera Synthetic Ltd operates in a relatively niche market, focusing on synthetic materials. The company has shown a commendable growth trajectory over the years, with its sales increasing from ₹19.58 Cr in March 2014 to ₹40.70 Cr in March 2023. This growth reflects a compound annual growth rate (CAGR) of approximately 10.95%, which is impressive, especially given the challenges posed by global supply chain disruptions and fluctuating raw material costs. The most recent quarterly report for September 2023 showed a slight dip in sales to ₹21.55 Cr, down from ₹40.71 Cr in March 2023. However, this could be seen as part of a seasonal trend rather than a cause for alarm. The company’s revenue growth seems to align with broader industry trends, suggesting a resilient demand for synthetic materials, potentially driven by their increasing applications in various sectors.
Profitability and Efficiency Metrics
Vera Synthetic’s profitability metrics present a mixed picture. The operating profit margin (OPM) stood at 8.32%, which is relatively modest but reflects effective cost management compared to historical figures. However, the recent fluctuations in OPM, which peaked at 15.51% in September 2020, indicate volatility that warrants attention. The company recorded a net profit of ₹2.03 Cr for the fiscal year 2025, translating to an earnings per share (EPS) of ₹4.11. This represents a slight improvement from ₹3.69 in the previous year. Despite these profits, the return on equity (ROE) of 9.07% and return on capital employed (ROCE) of 12.3% suggest there is room for improvement in generating returns on shareholders’ investments. The interest coverage ratio of 6735.86x is strikingly high, indicating that the company can comfortably meet its interest obligations, which is a significant strength.
Balance Sheet Strength and Financial Ratios
The balance sheet of Vera Synthetic reveals a robust financial position, particularly highlighted by its negligible borrowings of just ₹0.03 Cr. The company’s reserves have steadily increased to ₹20.00 Cr, which provides a solid buffer against potential downturns or unexpected expenses. The current ratio of 5.44 and quick ratio of 3.72 suggest that the company is well-positioned to cover its short-term liabilities, enhancing its liquidity profile. Furthermore, the price-to-book value ratio (P/BV) of 1.42x indicates a reasonable market valuation relative to its net assets. However, the asset turnover ratio of 1.68x suggests that while the company is generating sales effectively, there may be opportunities to enhance efficiency in asset utilization. Overall, the balance sheet appears strong, yet operational efficiency could be an area of focus for investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vera Synthetic Ltd illustrates a dominant promoter presence, with promoters holding 68.66% of the shares. This significant stake may instill confidence among retail investors, as it suggests alignment of interests between management and shareholders. The public shareholding has decreased significantly from approximately 40% in March 2020 to 31.34% in September 2023, which could indicate either a consolidation phase or a reduction in interest from retail investors. The number of shareholders has fluctuated, with a total of 115 shareholders reported recently. The absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) raises a flag, as institutional backing typically lends credibility and stability to a stock. This pattern may deter some investors who prefer companies with diversified ownership.
Outlook, Risks, and Final Insight
Looking ahead, Vera Synthetic faces a blend of opportunities and risks. The demand for synthetic materials is likely to remain strong, driven by various industries, but the company must navigate the challenges of fluctuating raw material prices and global economic uncertainties. The recent dip in quarterly sales could signal potential volatility, and the company’s reliance on a concentrated promoter shareholding may deter some investors. Moreover, the relatively low ROE indicates that while the company is profitable, there may be more effective ways to utilize equity for shareholder returns. Investors should weigh these aspects carefully. Overall, while Vera Synthetic Ltd presents a compelling case with its strong balance sheet and growth trajectory, potential investors should remain vigilant about market conditions and operational efficiency to fully realize the company’s potential.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vera Synthetic Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 103 Cr. | 26.8 | 797/25.8 | 1.00 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,635 Cr. | 162 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 47.0 Cr. | 3.68 | 8.65/3.55 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,815.77 Cr | 219.54 | 453.38 | 219.27 | 0.25% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.01 | 15.56 | 14.70 | 13.43 | 17.40 | 17.58 | 19.61 | 40.71 | 21.55 | 21.56 | 23.28 | 19.11 |
| Expenses | 16.37 | 13.97 | 12.42 | 13.36 | 16.57 | 15.35 | 17.93 | 37.78 | 21.21 | 20.26 | 21.23 | 17.52 |
| Operating Profit | 1.64 | 1.59 | 2.28 | 0.07 | 0.83 | 2.23 | 1.68 | 2.93 | 0.34 | 1.30 | 2.05 | 1.59 |
| OPM % | 9.11% | 10.22% | 15.51% | 0.52% | 4.77% | 12.68% | 8.57% | 7.20% | 1.58% | 6.03% | 8.81% | 8.32% |
| Other Income | 0.00 | 0.00 | 0.00 | 1.03 | 0.31 | -0.05 | 0.05 | 0.17 | 0.01 | 0.00 | 0.11 | 0.00 |
| Interest | 0.10 | 0.09 | 0.07 | 0.09 | 0.07 | 0.09 | 0.07 | 0.16 | 0.05 | 0.05 | 0.00 | 0.00 |
| Depreciation | 0.31 | 0.37 | 0.30 | 0.31 | 0.34 | 0.17 | 0.21 | 0.49 | 0.54 | 0.54 | 0.49 | 0.53 |
| Profit before tax | 1.23 | 1.13 | 1.91 | 0.70 | 0.73 | 1.92 | 1.45 | 2.45 | -0.24 | 0.71 | 1.67 | 1.06 |
| Tax % | 27.64% | 15.93% | 29.84% | 27.14% | 26.03% | 25.52% | 24.14% | 25.71% | 4.17% | 25.35% | 25.15% | 27.36% |
| Net Profit | 0.90 | 0.96 | 1.35 | 0.51 | 0.54 | 1.42 | 1.09 | 1.82 | -0.25 | 0.53 | 1.26 | 0.77 |
| EPS in Rs | 1.82 | 1.95 | 2.74 | 1.03 | 1.09 | 2.88 | 2.21 | 3.69 | -0.51 | 1.07 | 2.55 | 1.56 |
Last Updated: August 20, 2025, 1:30 am
Below is a detailed analysis of the quarterly data for Vera Synthetic Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 19.11 Cr.. The value appears to be declining and may need further review. It has decreased from 23.28 Cr. (Sep 2024) to 19.11 Cr., marking a decrease of 4.17 Cr..
- For Expenses, as of Mar 2025, the value is 17.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.23 Cr. (Sep 2024) to 17.52 Cr., marking a decrease of 3.71 Cr..
- For Operating Profit, as of Mar 2025, the value is 1.59 Cr.. The value appears to be declining and may need further review. It has decreased from 2.05 Cr. (Sep 2024) to 1.59 Cr., marking a decrease of 0.46 Cr..
- For OPM %, as of Mar 2025, the value is 8.32%. The value appears to be declining and may need further review. It has decreased from 8.81% (Sep 2024) to 8.32%, marking a decrease of 0.49%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.49 Cr. (Sep 2024) to 0.53 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 1.67 Cr. (Sep 2024) to 1.06 Cr., marking a decrease of 0.61 Cr..
- For Tax %, as of Mar 2025, the value is 27.36%. The value appears to be increasing, which may not be favorable. It has increased from 25.15% (Sep 2024) to 27.36%, marking an increase of 2.21%.
- For Net Profit, as of Mar 2025, the value is 0.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Sep 2024) to 0.77 Cr., marking a decrease of 0.49 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.56. The value appears to be declining and may need further review. It has decreased from 2.55 (Sep 2024) to 1.56, marking a decrease of 0.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.58 | 24.32 | 21.89 | 18.13 | 22.15 | 33.73 | 32.29 | 27.76 | 34.98 | 40.70 | 39.38 | 42.03 |
| Expenses | 18.67 | 23.37 | 21.02 | 17.17 | 19.86 | 31.03 | 29.22 | 25.43 | 31.93 | 37.77 | 35.74 | 38.60 |
| Operating Profit | 0.91 | 0.95 | 0.87 | 0.96 | 2.29 | 2.70 | 3.07 | 2.33 | 3.05 | 2.93 | 3.64 | 3.43 |
| OPM % | 4.65% | 3.91% | 3.97% | 5.30% | 10.34% | 8.00% | 9.51% | 8.39% | 8.72% | 7.20% | 9.24% | 8.16% |
| Other Income | 0.18 | 0.18 | 0.06 | 0.02 | 0.10 | 0.17 | 0.17 | 1.05 | 0.26 | 0.17 | 0.07 | 0.33 |
| Interest | 0.33 | 0.35 | 0.13 | 0.10 | 0.37 | 0.25 | 0.19 | 0.16 | 0.16 | 0.16 | 0.08 | 0.00 |
| Depreciation | 0.28 | 0.38 | 0.40 | 0.26 | 0.48 | 0.65 | 0.67 | 0.61 | 0.51 | 0.49 | 1.18 | 1.02 |
| Profit before tax | 0.48 | 0.40 | 0.40 | 0.62 | 1.54 | 1.97 | 2.38 | 2.61 | 2.64 | 2.45 | 2.45 | 2.74 |
| Tax % | 31.25% | 90.00% | 32.50% | 32.26% | 31.17% | 28.93% | 21.85% | 28.74% | 25.76% | 25.71% | 27.35% | 25.91% |
| Net Profit | 0.33 | 0.05 | 0.27 | 0.43 | 1.06 | 1.40 | 1.85 | 1.86 | 1.97 | 1.82 | 1.80 | 2.03 |
| EPS in Rs | 1.83 | 0.28 | 1.50 | 2.39 | 2.94 | 2.84 | 3.75 | 3.77 | 3.99 | 3.69 | 3.65 | 4.11 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -84.85% | 440.00% | 59.26% | 146.51% | 32.08% | 32.14% | 0.54% | 5.91% | -7.61% | -1.10% | 12.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | 524.85% | -380.74% | 87.25% | -114.44% | 0.07% | -31.60% | 5.37% | -13.53% | 6.52% | 13.88% |
Vera Synthetic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 45% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.80 | 1.80 | 1.80 | 1.80 | 3.60 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 |
| Reserves | 1.61 | 2.40 | 2.67 | 2.33 | 1.58 | 6.70 | 8.55 | 10.41 | 12.38 | 14.20 | 15.99 | 18.02 | 20.00 |
| Borrowings | 3.31 | 1.27 | 0.81 | 0.85 | 5.01 | 1.76 | 1.40 | 1.82 | 1.68 | 1.13 | 0.00 | 0.00 | 0.03 |
| Other Liabilities | 1.79 | 1.59 | 2.04 | 2.89 | 5.12 | 2.29 | 3.37 | 3.44 | 4.52 | 2.92 | 2.52 | 3.78 | 5.65 |
| Total Liabilities | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
| Fixed Assets | 2.01 | 2.41 | 2.40 | 1.06 | 3.45 | 3.97 | 4.01 | 4.47 | 3.05 | 6.08 | 6.57 | 5.65 | 5.27 |
| CWIP | 0.37 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6.13 | 4.28 | 4.92 | 6.81 | 11.86 | 11.72 | 14.25 | 16.14 | 20.47 | 17.11 | 16.88 | 21.09 | 25.35 |
| Total Assets | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
Below is a detailed analysis of the balance sheet data for Vera Synthetic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.94 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.94 Cr..
- For Reserves, as of Sep 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.02 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 1.98 Cr..
- For Borrowings, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.78 Cr. (Mar 2025) to 5.65 Cr., marking an increase of 1.87 Cr..
- For Total Liabilities, as of Sep 2025, the value is 30.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5.27 Cr.. The value appears to be declining and may need further review. It has decreased from 5.65 Cr. (Mar 2025) to 5.27 Cr., marking a decrease of 0.38 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 25.35 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2025) to 25.35 Cr., marking an increase of 4.26 Cr..
- For Total Assets, as of Sep 2025, the value is 30.62 Cr.. The value appears strong and on an upward trend. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
Notably, the Reserves (20.00 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.40 | -0.32 | 0.06 | 0.11 | -2.72 | 0.94 | 1.67 | 0.51 | 1.37 | 1.80 | 3.64 | 3.43 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54.81 | 46.83 | 45.69 | 36.04 | 136.28 | 82.67 | 92.01 | 83.36 | 89.01 | 82.15 | 27.06 | 37.95 |
| Inventory Days | 50.65 | 13.18 | 21.15 | 31.97 | 38.30 | 5.46 | 28.52 | 51.60 | 30.23 | 38.86 | 68.81 | 84.39 |
| Days Payable | 11.54 | 10.23 | 16.10 | 7.05 | 81.62 | 16.38 | 23.50 | 33.41 | 37.57 | 14.65 | 7.57 | 26.02 |
| Cash Conversion Cycle | 93.91 | 49.77 | 50.74 | 60.97 | 92.96 | 71.76 | 97.02 | 101.55 | 81.67 | 106.36 | 88.30 | 96.32 |
| Working Capital Days | 36.54 | 20.86 | 23.18 | 5.44 | 45.98 | 70.01 | 86.02 | 117.68 | 134.61 | 101.88 | 80.17 | 143.99 |
| ROCE % | 12.31% | 9.86% | 14.04% | 25.18% | 18.82% | 17.96% | 16.47% | 15.48% | 13.29% | 12.28% | 12.26% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Diluted EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Cash EPS (Rs.) | 6.18 | 6.02 | 4.67 | 5.01 | 4.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Revenue From Operations / Share (Rs.) | 85.44 | 79.80 | 82.48 | 70.89 | 56.95 |
| PBDIT / Share (Rs.) | 7.62 | 7.53 | 6.28 | 6.71 | 6.85 |
| PBIT / Share (Rs.) | 5.54 | 5.15 | 5.30 | 5.68 | 5.62 |
| PBT / Share (Rs.) | 5.54 | 4.98 | 4.97 | 5.36 | 5.29 |
| Net Profit / Share (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| PBDIT Margin (%) | 8.91 | 9.43 | 7.61 | 9.46 | 12.03 |
| PBIT Margin (%) | 6.48 | 6.44 | 6.42 | 8.01 | 9.86 |
| PBT Margin (%) | 6.48 | 6.24 | 6.02 | 7.56 | 9.28 |
| Net Profit Margin (%) | 4.80 | 4.56 | 4.46 | 5.62 | 6.60 |
| Return on Networth / Equity (%) | 8.83 | 8.58 | 9.51 | 11.36 | 12.09 |
| Return on Capital Employeed (%) | 11.91 | 12.13 | 13.28 | 15.23 | 16.66 |
| Return On Assets (%) | 7.57 | 7.65 | 7.84 | 8.36 | 9.00 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 | 0.06 | 0.08 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.09 | 0.08 |
| Asset Turnover Ratio (%) | 1.68 | 1.69 | 1.74 | 1.59 | 1.45 |
| Current Ratio (X) | 5.44 | 6.58 | 4.80 | 3.95 | 4.00 |
| Quick Ratio (X) | 3.72 | 4.56 | 3.91 | 3.55 | 3.38 |
| Inventory Turnover Ratio (X) | 4.08 | 4.29 | 7.26 | 5.38 | 4.94 |
| Interest Coverage Ratio (X) | 6735.86 | 44.96 | 19.25 | 21.30 | 20.70 |
| Interest Coverage Ratio (Post Tax) (X) | 3633.34 | 22.73 | 12.29 | 13.66 | 12.35 |
| Enterprise Value (Cr.) | 32.30 | 20.24 | 35.29 | 12.33 | 14.28 |
| EV / Net Operating Revenue (X) | 0.76 | 0.51 | 0.86 | 0.35 | 0.50 |
| EV / EBITDA (X) | 8.59 | 5.45 | 11.38 | 3.73 | 4.22 |
| MarketCap / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| Price / BV (X) | 1.42 | 1.23 | 1.89 | 0.74 | 1.04 |
| Price / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| EarningsYield | 0.06 | 0.06 | 0.05 | 0.15 | 0.11 |
After reviewing the key financial ratios for Vera Synthetic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 6.02 (Mar 24) to 6.18, marking an increase of 0.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 85.44. It has increased from 79.80 (Mar 24) to 85.44, marking an increase of 5.64.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.62. This value is within the healthy range. It has increased from 7.53 (Mar 24) to 7.62, marking an increase of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 5.15 (Mar 24) to 5.54, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 4.98 (Mar 24) to 5.54, marking an increase of 0.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For PBDIT Margin (%), as of Mar 25, the value is 8.91. This value is below the healthy minimum of 10. It has decreased from 9.43 (Mar 24) to 8.91, marking a decrease of 0.52.
- For PBIT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.44 (Mar 24) to 6.48, marking an increase of 0.04.
- For PBT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.24 (Mar 24) to 6.48, marking an increase of 0.24.
- For Net Profit Margin (%), as of Mar 25, the value is 4.80. This value is below the healthy minimum of 5. It has increased from 4.56 (Mar 24) to 4.80, marking an increase of 0.24.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.83. This value is below the healthy minimum of 15. It has increased from 8.58 (Mar 24) to 8.83, marking an increase of 0.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.91. This value is within the healthy range. It has decreased from 12.13 (Mar 24) to 11.91, marking a decrease of 0.22.
- For Return On Assets (%), as of Mar 25, the value is 7.57. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 7.57, marking a decrease of 0.08.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.68. It has decreased from 1.69 (Mar 24) to 1.68, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 5.44. This value exceeds the healthy maximum of 3. It has decreased from 6.58 (Mar 24) to 5.44, marking a decrease of 1.14.
- For Quick Ratio (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 2. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.08. This value is within the healthy range. It has decreased from 4.29 (Mar 24) to 4.08, marking a decrease of 0.21.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6,735.86. This value is within the healthy range. It has increased from 44.96 (Mar 24) to 6,735.86, marking an increase of 6,690.90.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3,633.34. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 3,633.34, marking an increase of 3,610.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 32.30. It has increased from 20.24 (Mar 24) to 32.30, marking an increase of 12.06.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 24) to 0.76, marking an increase of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 8.59. This value is within the healthy range. It has increased from 5.45 (Mar 24) to 8.59, marking an increase of 3.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For Price / BV (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.42, marking an increase of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vera Synthetic Ltd:
- Net Profit Margin: 4.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.91% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.83% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3633.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.6 (Industry average Stock P/E: 453.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Synthetic/Silk | Office No.UL-27, Pattani Plaza, Bhavnagar Gujarat 364002 | info@sujlonropes.com http://www.sujlonropes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sunil D Makwana | Chairman & Managing Director |
| Mrs. Meera S Makwana | Whole Time Director |
| Mr. Devjibhai P Makwana | Executive Director |
| Mr. Dineshbhai M Patel | Independent Director |
| Mrs. Bansari Parin Shah | Independent Director |
| Mr. Ravikumar B Adhiya | Independent Director |
FAQ
What is the intrinsic value of Vera Synthetic Ltd?
Vera Synthetic Ltd's intrinsic value (as of 09 December 2025) is 47.09 which is 32.63% lower the current market price of 69.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 34.5 Cr. market cap, FY2025-2026 high/low of 111/66.0, reserves of ₹20.00 Cr, and liabilities of 30.62 Cr.
What is the Market Cap of Vera Synthetic Ltd?
The Market Cap of Vera Synthetic Ltd is 34.5 Cr..
What is the current Stock Price of Vera Synthetic Ltd as on 09 December 2025?
The current stock price of Vera Synthetic Ltd as on 09 December 2025 is 69.9.
What is the High / Low of Vera Synthetic Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vera Synthetic Ltd stocks is 111/66.0.
What is the Stock P/E of Vera Synthetic Ltd?
The Stock P/E of Vera Synthetic Ltd is 12.6.
What is the Book Value of Vera Synthetic Ltd?
The Book Value of Vera Synthetic Ltd is 50.5.
What is the Dividend Yield of Vera Synthetic Ltd?
The Dividend Yield of Vera Synthetic Ltd is 0.00 %.
What is the ROCE of Vera Synthetic Ltd?
The ROCE of Vera Synthetic Ltd is 12.3 %.
What is the ROE of Vera Synthetic Ltd?
The ROE of Vera Synthetic Ltd is 9.07 %.
What is the Face Value of Vera Synthetic Ltd?
The Face Value of Vera Synthetic Ltd is 10.0.